Dominant negative mutants of mitogen-activated protein kinase pathway.
Arboleda
M J
MJ
Onyx Pharmaceuticals, Richmond, California 94806, USA.
Eberwein
D
D
Hibner
B
B
Lyons
J F
JF
D000818:Animals; D002448:Cell Adhesion; D002455:Cell Division; D015870:Gene Expression; D011905:Genes, ras; D006801:Humans; D015151:Immunoblotting; D048728:MAP Kinase Kinase Kinase 1; D051379:Mice; D008819:Mice, Nude; D020928:Mitogen-Activated Protein Kinases / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D009368:Neoplasm Transplantation; D010957:Plasmids / Q000235:genetics; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism; D019908:Proto-Oncogene Proteins c-raf / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D014162:Transfection; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
D017346:Protein Serine-Threonine Kinases; D019908:Proto-Oncogene Proteins c-raf; D020928:Mitogen-Activated Protein Kinases; D048728:MAP Kinase Kinase Kinase 1; C482576:MAP3K1 protein, human; C482578:Map3k1 protein, mouse